The session moves from evidence to experience, bringing together clinical evidence and real-world data to provide a practical perspective on the effectiveness of non-factor prophylaxis and its potential to improve outcomes beyond simply preventing bleeds.

Why attend? This session will help doctors build a deeper understanding of non-factor prophylaxis in haemophilia A and B without inhibitors, with a focus on its impact on bleed control and quality of life. Attendees will explore the evidence supporting these approaches and gain insights into how clinical outcomes translate into real-world patient care.